Skip to main content
The BMJ logoLink to The BMJ
letter
. 1996 Nov 2;313(7065):1142–1144. doi: 10.1136/bmj.313.7065.1142

Cost effectiveness of lowering cholesterol. Cost consequence analysis may be more useful to decision makers.

J Shepherd
PMCID: PMC2352419  PMID: 8916706

Full text

PDF

Page 1142

1142

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Pharoah P. D., Hollingworth W. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population. BMJ. 1996 Jun 8;312(7044):1443–1448. doi: 10.1136/bmj.312.7044.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  3. Sigurdsson E., Sigfusson N., Agnarsson U., Sigvaldason H., Thorgeirsson G. Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study. Int J Epidemiol. 1995 Feb;24(1):58–68. doi: 10.1093/ije/24.1.58. [DOI] [PubMed] [Google Scholar]
  4. Visser M. C., Koudstaal P. J., Erdman R. A., Deckers J. W., Passchier J., van Gijn J., Grobbee D. E. Measuring quality of life in patients with myocardial infarction or stroke: a feasibility study of four questionnaires in The Netherlands. J Epidemiol Community Health. 1995 Oct;49(5):513–517. doi: 10.1136/jech.49.5.513. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES